BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG) today reported the results of its annual shareholders’ meeting held this morning in Cary, North Carolina. At the meeting, shareholders elected Philip A. Incarnati and re-elected Gregory D. Jordan and Brian A. Markison, the Company’s President and Chief Executive Officer, to serve on the Company’s board of directors until the Company’s 2010 annual meeting. Mr. Markison became Chairman of the Company’s board of directors following the meeting in accordance with the board’s previously announced plan, succeeding Ted G. Wood, who will continue to serve on the board as its lead independent director.
